Used in research as a potent and selective inhibitor of Pim kinases, which are implicated in cell survival and proliferation. Shows potential in oncology studies, particularly in hematological malignancies such as leukemia and lymphoma. Investigated for its ability to induce apoptosis in cancer cells when used alone or in combination with other anticancer agents. Due to its mechanism of targeting signaling pathways involved in tumor progression, it serves as a tool compound in preclinical studies to validate Pim kinase inhibition as a therapeutic strategy. Not approved for clinical use; strictly for laboratory research.